Brennan Collis

ORCID: 0000-0002-9393-4536
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Pneumonia and Respiratory Infections
  • Congenital gastrointestinal and neural anomalies
  • Drug-Induced Adverse Reactions
  • Pneumocystis jirovecii pneumonia detection and treatment
  • Intestinal Malrotation and Obstruction Disorders
  • Antibiotic Resistance in Bacteria
  • Contact Dermatitis and Allergies
  • Congenital Anomalies and Fetal Surgery
  • Infection Control and Ventilation
  • COVID-19 and healthcare impacts
  • Esophageal and GI Pathology
  • Anorectal Disease Treatments and Outcomes
  • Neutropenia and Cancer Infections
  • Nosocomial Infections in ICU
  • Pharmacovigilance and Adverse Drug Reactions
  • COVID-19 epidemiological studies
  • Antifungal resistance and susceptibility
  • Fungal Infections and Studies
  • Bacterial Infections and Vaccines
  • Urticaria and Related Conditions
  • Diverticular Disease and Complications

Royal Children's Hospital
2017-2024

Murdoch Children's Research Institute
2024

The University of Melbourne
2017-2024

Alfred Health
2023-2024

Austin Health
2023-2024

Northern Hospital
2023

Peter Doherty Institute
2023

Multidrug-resistant bacterial pathogens like vancomycin-resistant Enterococcus faecium (VREfm) are a critical threat to human health1. Daptomycin is last-resort antibiotic for VREfm infections with novel mode of action2, but which resistance has been widely reported unexplained. Here we show that rifaximin, an unrelated used prophylactically prevent hepatic encephalopathy in patients liver disease3, causes cross-resistance daptomycin VREfm. Amino acid changes arising within the RNA...

10.1038/s41586-024-08095-4 article EN cc-by-nc-nd Nature 2024-10-23

Critically ill patients are vulnerable to penicillin allergy labels that may be incorrect. The validity of skin testing in intensive care units (ICUs) is uncertain. Many low risk, and validated tools exist identify those amenable direct oral challenge. This pilot randomised controlled trial explored the feasibility, safety, enteral challenge for low-risk critical illness. Consenting with a label (PAL) (PEN-FAST risk assessment score < 3) four ICUs (Melbourne, Australia) were 1:1 (250 mg...

10.1007/s00134-024-07448-x article EN cc-by-nc Intensive Care Medicine 2024-05-13

Abstract Multidrug-resistant bacterial pathogens like vancomycin-resistant Enterococcus faecium (VREfm) are a critical threat to human health. Daptomycin is last-resort antibiotic for VREfm infections with novel mode-of-action, but which resistance has surprisingly been widely reported unexplained. Here we show that rifaximin, an unrelated used prophylactically prevent hepatic encephalopathy in liver disease patients, causes cross-resistance daptomycin VREfm. Amino acid changes arising...

10.1101/2023.03.01.23286614 preprint EN cc-by-nc-nd medRxiv (Cold Spring Harbor Laboratory) 2023-03-05

We aimed to study the impact of anorectal malformation (ARM) type and sacral ratio on continence outcomes in children. secondarily compare by age group determine quality life (QoL) with different bowel regimens.

10.1097/sla.0000000000006606 article EN Annals of Surgery 2024-12-18

Journal Article Critical Microbiological Clues in a Critically Ill Patient With Pneumonia Get access Brennan Collis, Collis Department of Infectious Diseases, Alfred Health, Melbourne, Victoria, AustraliaMicrobiology Unit, Pathology, Australia Correspondence: B. 55 Commercial Rd, Victoria 3004, (b.collis@alfred.org.au); S. Khan, Australia. https://orcid.org/0000-0002-9393-4536 Search for other works by this author on: Oxford Academic PubMed Google Scholar Christina Guo, Guo Chris C Lee, Lee...

10.1093/cid/ciad729 article EN Clinical Infectious Diseases 2023-11-08
Coming Soon ...